-
-
-
-
-
-
-
Rhelion unit ships psilocybin drug to University of Calgary PTSD trial
-
-
-
-
-
-
-
Rhelion unit signs psilocybin supply deal with Dutch research center
-
-
-
-
-
-
-
Rhelion Life Sciences Confirms Further Delivery of Filament Health's PEX010 to Germany's First Psilocybin Compassionate Use Program
-
-
-
-
-
-
-
Rhelion Life Sciences Signs Agreement with University Health Network for Randomized Clinical Trial of Psilocybin in Parkinson's Disease Depression
-
-
-
-
-
-
-
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Military Veterans PTSD Study at ARQ National Psychotrauma Centre
-
-
-
-
-
-
-
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechani
-
-
-
-
-
-
-
Red Light Holland Announces Filament Health Shareholder Approval of Acquisition
-
1,204,296 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


